Status:
COMPLETED
The Antihypercholestrolemic Effect of a Combined Nutritional Supplementation of Standardized Extracts of Amla, Walnut, Red Yeast Rice and Olive
Lead Sponsor:
Liaquat University of Medical & Health Sciences
Collaborating Sponsors:
KU Leuven
Conditions:
Hyperlipidemia
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Nutraceutical lipid-lowering interventions are becoming increasingly popular, particularly among patients who are intolerant or refractory to prescription statins, or who desire alternative non-conven...
Detailed Description
The present exploratory study aimed to assess the safety, efficacy, and patient's satisfaction of a combined supplementation of amla, red yeast rice, olive, and walnut leaf extracts (Cholesfytol NG®) ...
Eligibility Criteria
Inclusion
- Age ≥ 21 years
- Both male or female
- Blood total cholesterol (TC) level ≥ 200 mg/dL
- Blood low-density lipoprotein cholesterol (LDL-C) level ≥ 130 mg/dL
- With or without myalgia and/or diabetes
- No prior treatment of cholesterol-lowering agents and/or patients whose cholesterol- lowering treatment did not allow them to reach LDL-C target
- Patients who had stopped their cholesterol-lowering treatment because of side effects including myalgia
Exclusion
- Pregnant nor breastfeeding patients
Key Trial Info
Start Date :
March 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
221 Patients enrolled
Trial Details
Trial ID
NCT06002893
Start Date
March 19 2020
End Date
July 31 2023
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques universitaires St-Luc and Institut de Recherche Expérimentale et Clinique (IREC), KU Leuven
Leuven, Belgium